This idea proposes targeting chondroitin sulfate proteoglycans (CSPGs) and perineuronal nets (PNNs) to enhance synaptic plasticity and memory in Alzheimer's disease. PNNs are lattice-like structures that encase neurons, particularly parvalbumin-expressing interneurons, and their degradation can restore neuronal plasticity that becomes impaired with age and neurodegeneration. [1]
| Dimension | Score | Rationale | [2]
|-----------|-------|-----------| [3]
| Novelty | 8 | First-in-class approach targeting PNN structural remodeling rather than conventional synaptic targets | [4]
| Mechanistic Rationale | 8 | Multiple validated evidence lines: CSPG degradation restores plasticity in AD mouse models; chondroitinase ABC improves memory; PNN reduction enables reactivation of learning in aged brains | [5]
| Addresses Root Cause | 7 | Targets synaptic plasticity deficit rather than amyloid/tau directly; enables functional recovery of cognitive circuits | [6]
| Delivery Feasibility | 6 | AAV-delivered enzyme or small molecule can target hippocampal neurons; blood-brain barrier remains challenge but enzyme therapies have precedent |
| Safety Plausibility | 7 | Spatialtemporal control critical; PNNs serve protective roles; engineered enzyme variants with neuronal specificity reduce off-target risk |
| Combinability | 8 | Highly synergistic with: cholinesterase inhibitors, AMPAR modulators, BDNF therapies, and cognitive training |
| Biomarker Duration | 7 | CSPG sulfation patterns in CSF; PNN component levels (aggrecan, versican); neuronal activity markers |
| De-risking Path | 7 | Mouse models available; chondroitinase ABC has proof-of-concept; enzyme engineering is straightforward |
| Multi-disease Potential | 9 | AD, PTSD (fear extinction), stroke recovery, traumatic brain injury, age-related cognitive decline |
| Patient Impact | 7 | Memory enhancement in AD patients could significantly improve quality of life; enables new learning |
| Risk | Likelihood | Impact | Mitigation |
|---|---|---|---|
| Off-target plasticity | Medium | High | Neuronal-specific promoters |
| Immunogenicity | Medium | Medium | PEGylation, humanized enzymes |
| BBB delivery | High | High | Intrathecal route, engineered variants |
Chondroitinase ABC improves memory in APPswe/PS1dE9 mice (Brückner et al. 2011). 2011. ↩︎
PNN removal enables fear extinction in aged mice (Gogolla et al. 2009). 2009. ↩︎
CSPG accumulation in aging and AD brain (Morawski et al. 2012). 2012. ↩︎
AAV-ChABC enables cortical plasticity (Bowes et al. 2019). 2019. ↩︎
Perineuronal nets and memory (Pizzorusso et al. 2002). 2002. ↩︎
Chondroitinase ABC in adult brain plasticity (Massey et al. 2006). 2006. ↩︎